Questioning the validity of clinically available breast cancer polygenic risk scores: comparison of two labs reveals discrepancies

Fam Cancer. 2022 Apr;21(2):125-127. doi: 10.1007/s10689-021-00260-2. Epub 2021 May 18.

Julia Wynn¹, Elana Levinson², Carrie Koval², Michelle E Ernst³, Wendy K Chung^{4

5}

¹ Department of Pediatrics, Columbia University Irving Medical Center, 1150 St. Nicholas Ave, Russ Berrie Pavilion, 6th Fl, Rm620, New York, NY, 10032, USA.
² Department of Medicine, Columbia University Irving Medical Center, 1150 St. Nicholas Ave, Russ Berrie Pavilion, 6th Fl, Rm620, New York, NY, 10032, USA.
³ Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA.
⁴ Department of Pediatrics, Columbia University Irving Medical Center, 1150 St. Nicholas Ave, Russ Berrie Pavilion, 6th Fl, Rm620, New York, NY, 10032, USA. wkc15@columbia.edu.
⁵ Department of Medicine, Columbia University Irving Medical Center, 1150 St. Nicholas Ave, Russ Berrie Pavilion, 6th Fl, Rm620, New York, NY, 10032, USA. wkc15@columbia.edu.

No abstract available

Publication types